Navigation Links
Watson Confirms Exalgo™ Patent Challenge
Date:12/14/2010

MORRISTOWN, N.J., Dec. 14, 2010 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.  Watson's Hydromorphone Hydrochloride Extended-release Tablets are a generic version of Mallinckrodt Inc.'s Exalgo™ tablets, which are indicated for once daily administration for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.

Mallinckrodt filed suit against Watson on December 10, 2010 in the United States District Court for the District of New Jersey seeking to prevent Watson from commercializing its product prior to the expiration of U.S. Patent No. 5,914,131.  Mallinckrodt's lawsuit was filed under the provisions of the Hatch-Waxman Act, resulting in a stay of final FDA approval of Watson's ANDA until April 29, 2013, or until final resolution of the matter before the court, whichever occurs sooner, subject to any other exclusivities.  

Based on available information, Watson believes it may be a "first applicant" to file an ANDA for the 8 mg, 12 mg, and 16 mg generic versions of Exalgo™ and, should its ANDA be approved, may be entitled to 180 days of generic market exclusivity.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a leading global specialty pharmaceutical company.  The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health.  Watson has operations in many of the world's established an
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO ... therapies for operable and inoperable solid tumor cancers, announced today ... 7 th Annual Phacilitate Immunotherapy Forum in ... Phacilitate will take place on January 26 at 10:30 a.m. ...
(Date:1/23/2015)... 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is ... Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... fiduciary duties to shareholders. On January 21, ... reporting that Advaxis had misrepresented the clinical data for ...
(Date:1/23/2015)... , Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned ... market share and grab a foothold in the hydroponic, hemp ... capabilities and a presence in the sector, and recently partnering ... growth of hemp and medical marijuana, iMD is committing to ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... Jan. 25, 2011 / PRNewswire/ -- ... through the Pharmacy Technician Certification Board (PTCB), a pioneer ... have earned the PTCB Certified Pharmacy Technician (CPhT) credential ... the Pharmacy Technician Certification Exam (PTCE) in 2010 alone. ...
... Jan. 25, 2011 Reportlinker.com announces that a new ... The Drug Delivery Device Market Outlook ... Drug delivery device manufacturers are experiencing ... their buying power and reducing the contract prices for ...
Cached Medicine Technology:Record Number of Pharmacy Technicians Seek Certification Through PTCB 2Record Number of Pharmacy Technicians Seek Certification Through PTCB 3Reportlinker Adds The Drug Delivery Device Market Outlook to 2015 2Reportlinker Adds The Drug Delivery Device Market Outlook to 2015 3
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 A ... issue of experience and person-centeredness in the long-term care ... towards action across the continuum. The paper, “The Power ... Continuum,” engages perspectives and practices of the patient, resident ...
(Date:1/22/2015)... January 22, 2015 Carinsurancesavings.biz has released a ... death and dismemberment insurance . , Purchasing an accidental ... be very advantageous. This type of rider provides benefits if ... can be considered a lesser form of life insurance. ...
(Date:1/22/2015)... 23, 2015 Recently, Weddingshe.com has added many ... has announced its highest annual revenues in the past three ... popular glamorous wedding dresses. , According to the sales manager ... dress promotions for them in 2015. This point can be ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... an effort to further promote visibility and adoption of the ... made AMA journals available via its subscription services, EBSCO will ... , Long known as both a subscription agency ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Lower-Auto-Insurance.com has released a ... kit in a car for reducing the costs of an ... will also be able to get lower prices for their vehicle ... an important role in determining policy costs. Because of this, ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... PARIS and MARSEILLE, France, January 11 ... signing of a,scientific collaboration agreement in the breast cancer domain. ... Ipsogen,s,MapQuant Dx Grade Genomic, HER2 and HR tests will be ... patients treated at the Institut,Curie. The aim of this collaboration ...
... , CHICAGO, Jan. 11 ... Stimulus Program , making it safe and easy for physicians ... qualify for significant federal incentives. , (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ... a guarantee that the Allscripts EHR they select will meet ...
... , , ... MDRX ) announced today that Renaissance Medical Management Company (RMMC) ... Practice Management solution to automate and connect clinical and ... medicine physicians. The new service offering from RMMC builds upon the ...
... ... months and shared his story on ABC,s Good Morning America on January 8, 2010 , ... New York, NY (PRWEB) January 11, 2010 -- ... ago, kicked off 2010 with an appearance on ABC,s Good Morning America last Friday, feeling and ...
... ... simply spelling correctly the Hebrew word Sun ( SheMeSh éÞé) in English Letters as ... ... years of research, Joseph Lanyadoo concludes that language was neither invented by humans ...
... , CHICAGO, Jan. 10 Allscripts-Misys Healthcare ... for the three and six months ended November 30, 2009. ... Highlights: , Total revenue of $169.3 million; non-GAAP ... cents; non-GAAP earnings per share of $0.16 cents Net income ...
Cached Medicine News:Health News:The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer 2Health News:The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer 3Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 2Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 3Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 4Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 5Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 6Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 2Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 3Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 4Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 5Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 6Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 7Health News:Happy New Year for Marty: Arizona Man Drops 164 Pounds on Dr. Siegal's COOKIE DIET and Appears on ABC's Good Morning America 2Health News:Happy New Year for Marty: Arizona Man Drops 164 Pounds on Dr. Siegal's COOKIE DIET and Appears on ABC's Good Morning America 3Health News:New 20 Year Research Confirms the Biblical Assertion that Hebrew is the Original Proto-Language Confounded By the Gods 2Health News:New 20 Year Research Confirms the Biblical Assertion that Hebrew is the Original Proto-Language Confounded By the Gods 3Health News:New 20 Year Research Confirms the Biblical Assertion that Hebrew is the Original Proto-Language Confounded By the Gods 4Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 13Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 14Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 15Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 16Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 17Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 18
The Guidant Fineline leads are bipolar endocardial and designed for permanent implantation with pulse generators for cardiac pacing....
... The Guidant Flextend lead ... pace/sense lead with an ... extendable/retractable helix design offers ... for permanent implantation in ...
The RU is a low profile implantable bipolar tined permanent pacing lead for stimulation of either the atrium (J model) or the ventricle (straight model)....
... The Vitatron Crystalline lead ... specifically designed for optimal sensing ... reducing the sensing of far-field ... Crystalline leads allow a higher ...
Medicine Products: